An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models

MLA

Morelli, Kathryn H., et al. “An RNA-Targeting CRISPR–Cas13d System Alleviates Disease-Related Phenotypes in Huntington’s Disease Models.” Nature Neuroscience, no. Preprints, Jan. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41593-022-01207-1.

APA

Morelli, K. H., Wu, Q., Gosztyla, M. L., Liu, H., Yao, M., Zhang, C., Chen, J., Marina, R. J., Lee, K., Jones, K. L., Huang, M. Y., Li, A., Smith-Geater, C., Thompson, L. M., Duan, W., & Yeo, G. W. (2022). An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models. Nature Neuroscience, Preprints, 1–12. https://doi.org/10.1038/s41593-022-01207-1

Chicago

Morelli, Kathryn H., Qian Wu, Maya L. Gosztyla, Hongshuai Liu, Minmin Yao, Chuangchuang Zhang, Jiaxu Chen, et al. 2022. “An RNA-Targeting CRISPR–Cas13d System Alleviates Disease-Related Phenotypes in Huntington’s Disease Models.” Nature Neuroscience, no. Preprints (January): 1–12. doi:10.1038/s41593-022-01207-1.